Trial Profile
A Study to Evaluate the Effects of Botulinum Toxin on Cognition in Patients with Cranial Dystonia, Hemifacial Spasm and Cervical Dystonia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dystonia; Spasm; Torticollis
- Focus Therapeutic Use
- 21 Aug 2015 New trial record
- 23 Jun 2015 Results presented at the 1st Congress of the European Academy of Neurology.